Growth/Differentiation Factor 8 Market Report

Global and Region Growth/Differentiation Factor 8 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：217
  • REPORT CODE：GMM978086
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Growth/Differentiation Factor 8 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Growth/Differentiation Factor 8market, defines the market attractiveness level of Growth/Differentiation Factor 8 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Growth/Differentiation Factor 8 industry, describes the types of Growth/Differentiation Factor 8 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Growth/Differentiation Factor 8 market and the development prospects and opportunities of Growth/Differentiation Factor 8 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Growth/Differentiation Factor 8 market in Chapter 13.

    By Player:

    • Eli Lilly and Company

    • Regeneron Pharmaceuticals, Inc

    • Bristol-Myers Squibb Company

    • Acceleron Pharma, Inc

    • Sarepta Therapeutics, Inc

    • Milo Biotechnology LLC

    • Scholar Rock, Inc

    • Pfizer Inc

    • Atara Biotherapeutics, Inc

    By Type:

    • OSX-200

    • SRK-015

    • ACE-2494

    • ACE-2798

    • BMS-986089

    • Others

    By End-User:

    • Becker Muscular Dystrophy

    • Fibrosis

    • Myelofibrosis

    • Sickle Cell Disease

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Growth/Differentiation Factor 8 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Growth/Differentiation Factor 8 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Growth/Differentiation Factor 8 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Growth/Differentiation Factor 8 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Growth/Differentiation Factor 8 Market Analysis and Outlook to 2022

    • 7.1 Global Growth/Differentiation Factor 8 Consumption (2017-2022)

    • 7.2 United States Growth/Differentiation Factor 8 Consumption (2017-2022)

    • 7.3 Europe Growth/Differentiation Factor 8 Consumption (2017-2022)

    • 7.4 China Growth/Differentiation Factor 8 Consumption (2017-2022)

    • 7.5 Japan Growth/Differentiation Factor 8 Consumption (2017-2022)

    • 7.6 India Growth/Differentiation Factor 8 Consumption (2017-2022)

    • 7.7 South Korea Growth/Differentiation Factor 8 Consumption (2017-2022)

    8 Region and Country-wise Growth/Differentiation Factor 8 Market Analysis and Outlook to 2028

    • 8.1 Global Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    • 8.2 United States Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    • 8.3 Europe Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    • 8.4 China Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    • 8.5 Japan Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    • 8.6 India Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    • 8.7 South Korea Growth/Differentiation Factor 8 Consumption Forecast (2022-2028)

    9 Global Growth/Differentiation Factor 8 Market Outlook by Types and Applications to 2022

    • 9.1 Global Growth/Differentiation Factor 8 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global OSX-200 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global SRK-015 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global ACE-2494 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ACE-2798 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global BMS-986089 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Growth/Differentiation Factor 8 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Becker Muscular Dystrophy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Fibrosis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Myelofibrosis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Sickle Cell Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Growth/Differentiation Factor 8 Market Outlook by Types and Applications to 2028

    • 10.1 Global Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global OSX-200 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global SRK-015 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global ACE-2494 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ACE-2798 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global BMS-986089 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Becker Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Fibrosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Myelofibrosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Sickle Cell Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Growth/Differentiation Factor 8 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Growth/Differentiation Factor 8 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Growth/Differentiation Factor 8 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Growth/Differentiation Factor 8 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Growth/Differentiation Factor 8 Market Competitive Analysis

    • 14.1 Eli Lilly and Company

      • 14.1.1 Eli Lilly and Company Company Details

      • 14.1.2 Eli Lilly and Company Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly and Company Growth/Differentiation Factor 8 Product and Service

    • 14.2 Regeneron Pharmaceuticals, Inc

      • 14.2.1 Regeneron Pharmaceuticals, Inc Company Details

      • 14.2.2 Regeneron Pharmaceuticals, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Regeneron Pharmaceuticals, Inc Growth/Differentiation Factor 8 Product and Service

    • 14.3 Bristol-Myers Squibb Company

      • 14.3.1 Bristol-Myers Squibb Company Company Details

      • 14.3.2 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Product and Service

    • 14.4 Acceleron Pharma, Inc

      • 14.4.1 Acceleron Pharma, Inc Company Details

      • 14.4.2 Acceleron Pharma, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Acceleron Pharma, Inc Growth/Differentiation Factor 8 Product and Service

    • 14.5 Sarepta Therapeutics, Inc

      • 14.5.1 Sarepta Therapeutics, Inc Company Details

      • 14.5.2 Sarepta Therapeutics, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sarepta Therapeutics, Inc Growth/Differentiation Factor 8 Product and Service

    • 14.6 Milo Biotechnology LLC

      • 14.6.1 Milo Biotechnology LLC Company Details

      • 14.6.2 Milo Biotechnology LLC Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Milo Biotechnology LLC Growth/Differentiation Factor 8 Product and Service

    • 14.7 Scholar Rock, Inc

      • 14.7.1 Scholar Rock, Inc Company Details

      • 14.7.2 Scholar Rock, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Scholar Rock, Inc Growth/Differentiation Factor 8 Product and Service

    • 14.8 Pfizer Inc

      • 14.8.1 Pfizer Inc Company Details

      • 14.8.2 Pfizer Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Inc Growth/Differentiation Factor 8 Product and Service

    • 14.9 Atara Biotherapeutics, Inc

      • 14.9.1 Atara Biotherapeutics, Inc Company Details

      • 14.9.2 Atara Biotherapeutics, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Atara Biotherapeutics, Inc Growth/Differentiation Factor 8 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Growth/Differentiation Factor 8

    • Figure Growth/Differentiation Factor 8 Picture

    • Table Global Growth/Differentiation Factor 8 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Growth/Differentiation Factor 8 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Growth/Differentiation Factor 8 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Growth/Differentiation Factor 8 Consumption by Country (2017-2022)

    • Figure United States Growth/Differentiation Factor 8 Consumption and Growth Rate (2017-2022)

    • Table Europe Growth/Differentiation Factor 8 Consumption and Growth Rate (2017-2022)

    • Figure China Growth/Differentiation Factor 8 Consumption and Growth Rate (2017-2022)

    • Figure Japan Growth/Differentiation Factor 8 Consumption and Growth Rate (2017-2022)

    • Figure India Growth/Differentiation Factor 8 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Growth/Differentiation Factor 8 Consumption and Growth Rate (2017-2022)

    • Figure Global Growth/Differentiation Factor 8 Consumption Forecast by Country (2022-2028)

    • Figure United States Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Growth/Differentiation Factor 8 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global OSX-200 Consumption and Growth Rate (2017-2022)

    • Figure Global SRK-015 Consumption and Growth Rate (2017-2022)

    • Figure Global ACE-2494 Consumption and Growth Rate (2017-2022)

    • Figure Global ACE-2798 Consumption and Growth Rate (2017-2022)

    • Figure Global BMS-986089 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Becker Muscular Dystrophy Consumption and Growth Rate (2017-2022)

    • Figure Global Fibrosis Consumption and Growth Rate (2017-2022)

    • Figure Global Myelofibrosis Consumption and Growth Rate (2017-2022)

    • Figure Global Sickle Cell Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global OSX-200 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global SRK-015 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ACE-2494 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ACE-2798 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BMS-986089 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Becker Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fibrosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Myelofibrosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sickle Cell Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Growth/Differentiation Factor 8 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Growth/Differentiation Factor 8 Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Growth/Differentiation Factor 8 Product and Service

    • Table Regeneron Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals, Inc Growth/Differentiation Factor 8 Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Product and Service

    • Table Acceleron Pharma, Inc (Foundation Year, Company Profile and etc.)

    • Table Acceleron Pharma, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acceleron Pharma, Inc Growth/Differentiation Factor 8 Product and Service

    • Table Sarepta Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Sarepta Therapeutics, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sarepta Therapeutics, Inc Growth/Differentiation Factor 8 Product and Service

    • Table Milo Biotechnology LLC (Foundation Year, Company Profile and etc.)

    • Table Milo Biotechnology LLC Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Milo Biotechnology LLC Growth/Differentiation Factor 8 Product and Service

    • Table Scholar Rock, Inc (Foundation Year, Company Profile and etc.)

    • Table Scholar Rock, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Scholar Rock, Inc Growth/Differentiation Factor 8 Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Growth/Differentiation Factor 8 Product and Service

    • Table Atara Biotherapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Atara Biotherapeutics, Inc Growth/Differentiation Factor 8 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atara Biotherapeutics, Inc Growth/Differentiation Factor 8 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US